ARSOFT has strengthened its position as a leading technology company in military digital health with the selection of its platform LAIA XR by NATO, within the Innovation Working Group of the CWIX 2025 (Coalition Warrior Interoperability eXploration, eXperimentation, eXamination eXercise). This international event aims to improve the interoperability of allied capabilities in multi-domain operations.
Key participation in CWIX 2025: Poland, Denmark, and Türkiye
The main exercise was held in Bydgoszcz (Poland), with preparatory phases in Denmark and Türkiye, bringing together dozens of allied countries and technology companies in realistic operational scenarios. In this context, ARSOFT has played an active role in the medical area, participating in the Focus Area LOGMED, focused on improving logistical and medical capabilities in tactical environments.
LAIA XR: Disruptive technology for military surgery
Recognized by NATO as an innovative solution in military medicine, LAIA XR enables advanced surgical planning in critical situations, covering levels from ROL 2 to ROL 4. With over 2,000 successful clinical use cases in civilian environments, its adaptation to military settings strengthens deployed medical support in international missions.
Key features of LAIA XR
· Immediate access to previously acquired medical scans.
· High-resolution 3D anatomical visualization.
· Faster and safer clinical decision-making through AI integration.
· Real-time remote support from specialists at other operational points.
· Easy to use in field hospitals and resource-limited environments.
· Full interoperability with existing military medical systems.
Technology aligned with NATO’s strategic goals
LAIA XR complies with the standards of the NATO Defence Planning Process (NDPP) by:
· Standardizing medical procedures.
· Optimizing medical logistics by reducing physical loads and materials.
· Enhancing joint training for military medical personnel.
A step forward in military medical interoperability
ARSOFT’s participation in CWIX 2025 confirms LAIA XR as a key dual-use technology for the future of operational healthcare. This recognition reinforces ARSOFT’s commitment to defense innovation, while also advancing medical interoperability and the development of solutions aligned with the strategic objectives of the Atlantic Alliance.
